Matthew Whinery, MD
Otolaryngology · Colorado Springs, CONPI 1477796332
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,202 of the $2,879 with a category attached, or 76.5%. 15 manufacturers reported payments, led by Stryker at 33.3% of the total. Reporting peaked in 2020 at $831 and has fallen 70.2% since, to $248 in 2025.
Across 86 payments — averaging $33.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$958
- AstraZeneca$409
- GSK$343
- Inspire Medical Systems, Inc.$327
- Sanofi$316
- Regeneron Healthcare Solutions, Inc.$152
- plus $374 from 9 others
What the payments were for
- Travel & lodging$67724%
- Food & beverage$2,20276%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 10 | $958 |
| AstraZeneca | 19 | $409 |
| GSK | 13 | $343 |
| Inspire Medical Systems, Inc. | 3 | $327 |
| Sanofi | 15 | $316 |
| Regeneron Healthcare Solutions, Inc. | 8 | $152 |
| Aerin Medical Inc. | 6 | $136 |
| Optinose US, Inc. | 4 | $71 |
| Pfizer | 2 | $48 |
| Neurent Medical Limited | 1 | $29 |
| Intersect ENT, Inc. | 1 | $24 |
| Octapharma USA, Inc. | 1 | $18 |
| Amgen | 1 | $17 |
| LEO Pharma Inc. | 1 | $15 |
| Kaleo, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,879 in reported general payments places this provider in the 75th percentile of 174 otolaryngology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Budesonide | 17 | $3,004 |
| Ipratropium Bromide | 58 | $1,626 |
| Famotidine | 62 | $1,245 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 11 | $1,198 |
| Cevimeline Hcl | 14 | $1,013 |
| Pantoprazole Sodium | 82 | $705 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 62 | $628 |
| Azelastine Hcl | 23 | $606 |
| Pilocarpine Hcl | 11 | $557 |
| Mupirocin | 57 | $504 |
| Doxycycline Hyclate | 55 | $499 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 74 | $440 |
| Ofloxacin | 11 | $291 |
| Lidocaine Hcl ViscousLidocaine Hcl | 15 | $153 |
| Cephalexin | 26 | $149 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Colorado Springs
- Barton KnoxColorado Springs$164K
- Nicholas BeckmannColorado Springs$151K
- Michael WilhelmColorado Springs$76K
- Robert KellerColorado Springs$45K
- David BookColorado Springs$5K
- Edgar GallowayColorado Springs$5K
- Cameron ToddColorado Springs$4K
- Jonathan ArnholtColorado Springs$4K
- Elycia Kazemian-MarviColorado Springs$4K
- Jennifer ReavisColorado Springs$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.